Patients with T1D exhibited a reduction in CD3-CD16+ and CD3-CD56+ NK cell subsets (P = 0.019 and 0.0227, respectively) compared to HD (Figures 1C, D, Table 2). This evidence concerns the gene NCAM1 and type 1 diabetes mellitus.